Mission Bio
PrivateLast Round
Early Funding
Aug 5, 2025
Total Funding Raised
$112M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Mission Bio is a life sciences company that develops and commercializes the Tapestri Platform, a precision genomics tool for high-throughput single-cell multi-omics analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mission Bio Comparables
Compare Mission Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singleron Biotechnologies | 90% | |
| BioSkryb Genomics | 86% | |
| Atrandi Biosciences | 80% | |
Mission Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 5, 2025 | ||||
| Series C | Aug 13, 2020 | ||||
| Grant | Oct 10, 2019 | ||||
| Series B | Dec 13, 2018 | ||||
| Series A | Oct 17, 2017 | ||||
Seed | Feb 6, 2017 |
Key People
Founding team and executive leadership
Mission Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series C |
| Cota Capital | Early Funding, Series B, Series C |
| National Cancer Institute | Grant |
| StartX | Series A |
| Keiretsu Forum | Series A, Seed |
| Ally Bridge Group | Early Funding |
| Agilent Ventures | Early Funding, Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2025
New product announced at the ASH 2025 conference.
- Nov 20, 2025
Launched Tapestri Single-Cell Targeted DNA + RNA Assay at ASH 2025.
Mission Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mission Bio's valuation, stock price, and market status.